Resultados de la búsqueda 91-100 of 12070 for Selegiline

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

4. Neurología - Ensayos clínicos - Mayo Clinic

   This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

5. Radiología - Ensayos clínicos - Mayo Clinic

   Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

6. Hematología - Ensayos clínicos - Mayo Clinic

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

7. Radiología - Ensayos clínicos - Mayo Clinic

   Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

8. Psiquiatría y psicología - Ensayos clínicos

   FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...

9. Radiología - Ensayos clínicos - Mayo Clinic

   Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

10. Ensayos clínicos - Neurología

    The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. Droxidopa ...